Baricitinib: From Rheumatoid Arthritis to COVID-19

    April 2021 in “ Journal of clinical pharmacology ”
    Sara Assadiasl, Yousef Fatahi, Banafsheh Mosharmovahed … Mohammad Hossein Nicknam
    Studysummary This review discusses baricitinib's applications for various inflammatory disorders and highlights its promising efficacy alongside potential adverse effects, advocating for further research before it becomes a standard treatment.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on onlinelibrary.wiley.com →
    Discuss this study in the Community →

    Research cited in this study 2

    1. Treatment of Severe Alopecia Areata with Baricitinib JAAD Case Reports · 2019
    2. Reversal of Alopecia Areata Following Treatment With the JAK1/2 Inhibitor Baricitinib EBioMedicine · 2015